E. Ozaslan Et Al. , "Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%," 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease , vol.103, Barcelona, Spain, pp.74, 2016
Ozaslan, E. Et Al. 2016. Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease , (Barcelona, Spain), 74.
Ozaslan, E., Koca, S., Sevinc, A., Hacioglu, B., Ozcelik, M., Duran, A. O., ... Yildiz, Y.(2016). Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20% . 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease (pp.74). Barcelona, Spain
Ozaslan, E. Et Al. "Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%," 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 2016
Ozaslan, E. Et Al. "Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%." 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease , Barcelona, Spain, pp.74, 2016
Ozaslan, E. Et Al. (2016) . "Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%." 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease , Barcelona, Spain, p.74.
@conferencepaper{conferencepaper, author={E. Ozaslan Et Al. }, title={Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%}, congress name={13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease}, city={Barcelona}, country={Spain}, year={2016}, pages={74} }